3 Things to Watch at Momenta Pharmaceuticals

By Maxx Chatsko Despite its name, Momenta Pharmaceuticals (NASDAQ:MNTA  ) has been losing steam since the end of 2011 with revenue falling 97% in the last nine months. The company ...

Gilead Earnings Blaze a Star-Studded Future

By Dan Carroll The global HIV market supports a large and lucrative business environment. With more than $13 billion in antiretroviral drug sales in 2011 — to just the United ...

Bayer, J&J Sign Partner Deal With Portola for Xarelto Antidote

By Naomi Kresge Bayer AG (BAYN) and Johnson & Johnson (JNJ) will work together with Portola Pharmaceuticals Inc. to quell doctors’ concerns about the lack of an antidote ...

Incyte Pharmaceuticals Is Primed For A Run

By Paul Jaschke Incyte Corporation (INCY) is focused on discovering, developing, and commercializing novel small molecule drugs for serious, unmet oncology and inflammatory diseases ...

Everybody Wins If Endo Health Is Acquired By Warner Chilcott Or Valeant

By Jake King Last week, a Reuters article indicated that Endo Health Solutions (ENDP) is exploring options to sell itself, citing Valeant Pharmaceuticals (VRX) and Warner Chilcott ...

Warner Chilcott Announces FDA Approval of New Ulcerative Colitis Product

By Warner Chilcott (GLOBE NEWSWIRE) — Warner Chilcott plc (WCRX) today announced that the United States Food and Drug Administration (FDA) has approved its new 400 mg mesalamine ...

Hemispherx’s Chronic Fatigue Drug Rejected by FDA

By Brett Chase The agency says Ampligen needs additional testing to show that it works and is safe. The company says it will appeal the decision and implores hunger striker to start ...

Glaxo Clashes With PhRMA Over Data Disclosure

By Ed Silverman Just how heated can the controversy over disclosing clinical trial get? One day after the US pharmaceutical industry trade group bashed the cry to release patient-level ...

FDA should do more with its authority over tobacco products

By Editorial Board IN 2009, PRESIDENT Obama signed the Tobacco Control Act, which gave the Food and Drug Administration (FDA) authority over tobacco products. It was a signal moment ...

Delcath gets boost from German government

By Barbara Pinckney Delcath Systems Inc. is poised to grow its market in Germany after getting the green light from the country’s federal reimbursement agency. The New York City-based ...

FDA Issues Final Rule to Give Agency More Authority to Detain Adulterated Food

BY NEWS DESK  The U.S. Food and Drug Administration (FDA) on Monday announced a final rule strengthening the agency’s authority to use administrative detention to prevent potentially ...

Hemispherx says FDA rejects fatigue drug application

(Reuters) – Hemispherx Biopharma Inc said U.S. regulators had declined to approve its new drug application for Ampligen, its experimental drug for treating chronic fatigue syndrome, ...
Page 5 of 55« First...34567...102030...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS